Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.

Industry News Archive

Upcoming Lynparza and Enhertu Virtual Programs

Join AstraZeneca for a series of expert-led discussions on Lynparza® (olaparib), Lynparza® + bevacizumab, and Enhertu®:

Enhertu® (fam-trastuzumab deruxtecan-nxki)
Wednesday, September 16, 2020
Presented by: Maria Theodoulou, MD, Memorial Sloan-Kettering Cancer Center
Learn More & Register

Lynparza® (olaparib) and Lynparza® + bevacizumab
Tuesday, September 22, 2020
Presented by: Anne O’Dea, MD, University of Kansas Medical Center, and Virginia Kaklamani, MD, DSc, MSCI, University of Texas Health Science Center at San Antonio
Learn More & Register

Wednesday, September 23, 2020
Presented by: 
Sharyn Lewin, MD, FACS, Holy Name Medical Center
Learn More & Register

Wednesday, September 30, 2020
Presented by: Yuan Yuan, MD, PhD, City of Hope Comprehensive Cancer Center
Learn More & Register

1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
Email Us